how many people use glp-1 Take Medications in the US How oral GLP-1s could reshape

In December 2025, the administration also introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, a five year CMS Innovation Center (CMMI) model that intends to expand access to obesity drugs in Medicaid and Medicare by negotiating lower GLP-1 prices with manufacturers

They were initially developed as diabetes treatments but have more recently been repurposed for obesity management

What to know about berberine Pharmacy Times

Minimal-Dose Resistance Training for Improving Muscle Mass, Strength, and Function: A Narrative Review of Current Evidence and Practical Considerations

It will help you understand some side effects that are rare but very serious and that people should know

The interaction does not prevent using these medications together, but it may require levothyroxine dose adjustments as T4 levels may run higher than expected